In a cohort of 102 non-MYCN-amplified, untreated, primary NB tumors, high levels of inflammation-related genes characterizing M2 macrophages and a restricted gene signature (IL-6, IL-6R, IL-10, and TGF-β) were found to correlate with a worse prognosis [46]. This evidence concerns the gene IL6 and neuroblastoma.